Director/PDMR Shareholding

March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG)

Notification of transactions by persons discharging managerial responsibilities

1. Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA")
a) Name Flemming Ornskov
2. Reason for the notification
a) Position / status Chief Executive Officer - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares ("ADSs")

 

 
Identification code ISIN: US82481R1068
b) Nature of the transaction Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 9, 2021.
c) Price(s) and volume(s) Price(s) Volume(s)
$0 3,490
d) Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e) Date of the transaction March 9, 2018
f) Place of the transaction N/A

 

1. Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA")
a) Name Joanne Cordeiro
2. Reason for the notification
a) Position / status Chief Human Resources Officer - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares ("ADSs")

 

 
Identification code ISIN: US82481R1068
b) Nature of the transaction Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 9, 2021.
c) Price(s) and volume(s) Price(s) Volume(s)
$0 820
d) Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e) Date of the transaction March 9, 2018
f) Place of the transaction N/A

 

1. Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA")
a) Name Bill Mordan
2. Reason for the notification
a) Position / status General Counsel and Company Secretary - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares ("ADSs")

 

 
Identification code ISIN: US82481R1068
b) Nature of the transaction Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 9, 2021.
c) Price(s) and volume(s) Price(s) Volume(s)
$0 1,033
d) Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e) Date of the transaction March 9, 2018
f) Place of the transaction N/A

 

1. Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA")
a) Name Perry Sternberg
2. Reason for the notification
a) Position / status Head of US Commercial - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares ("ADSs")

 

 
Identification code ISIN: US82481R1068
b) Nature of the transaction Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 9, 2021.
c) Price(s) and volume(s) Price(s) Volume(s)
$0 715
d) Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e) Date of the transaction March 9, 2018
f) Place of the transaction N/A

 

1. Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA")
a) Name Kim Stratton
2. Reason for the notification
a) Position / status Head of International Commercial - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc Ordinary Shares of 5 pence each ("Ordinary Shares")

 

 
Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Receipt of Restricted Stock Units ("RSUs") in respect of notional Ordinary Shares awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 9, 2021.
c) Price(s) and volume(s) Price(s) Volume(s)
£0 3,891
d) Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e) Date of the transaction March 9, 2018
f) Place of the transaction N/A

 

1. Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA")
a) Name Matt Walker
2. Reason for the notification
a) Position / status Head of Technical Operations - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares ("ADSs")

 

 
Identification code ISIN: US82481R1068
b) Nature of the transaction Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 9, 2021.
c) Price(s) and volume(s) Price(s) Volume(s)
$0 919
d) Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e) Date of the transaction March 9, 2018
f) Place of the transaction N/A

 

Oliver Strawbridge

Senior Assistant Company Secretary

For further information please contact:

 

Investor Relations    
Christoph Brackmann christoph.brackmann@shire.com +41 795 432 359
Robert Coates rcoates@shire.com +44 203 549 0874
Sun Kim sun.kim@shire.com +1 617 588 8175
Media    
Katie Joyce kjoyce@shire.com  +1 781 482 2779

 

NOTES TO EDITORS

 

About Shire

 

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

 

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people's lives with medicines that have a meaningful impact on patients and all who support them on their journey.

 

www.shire.com

 

Ads